Celsi Fulvio, Staffa Paola, Lamba Martino, Castro Veronica, Chermetz Maddalena, Orzan Eva, Sagredini Raffaella, Barbi Egidio
Institute for Maternal and Child Health-IRCCS "Burlo Garofolo", 65/1 Via dell'Istria, 34137 Trieste, Italy.
Department of Medical, Surgery and Health Sciences, University of Trieste, 34149 Trieste, Italy.
Life (Basel). 2022 Jan 28;12(2):202. doi: 10.3390/life12020202.
Tonsillectomy is one of the most common surgical procedures performed in children as a treatment for obstructive sleep apnea due to tonsil hypertrophy or highly recurrent tonsillitis. Odynophagia, associated with food refusal for the first few days, is a common post-operative complaint. Available drugs for pain management, while efficacious, present some drawbacks, and a novel strategy would be welcome. Photobiomodulation (PBMT), in this context, can represent a possible choice, together with pharmacological therapy. The aim of this study was to evaluate PBMT effects compared to standard pain therapy on nociceptive sensation at different time points and administration of painkiller.
A registered, controlled, randomized, double-blind clinical trial was performed. Twenty-two patients were recruited and divided into laser-treated (T) or untreated (UT) groups, based on random assignment. In T group, immediately after tonsillectomy, performed with cold dissection technique, laser light was applied to the surgery site (using a Cube 4 from Eltech K-Laser s.r.l., Treviso, Italy), and then hemostasis was performed using bismuth subgallate paste. In C group, the same procedure was performed, except that laser light was switched off. The primary outcome was the difference in pain scores between subject receiving photobiomodulation (PBMT) and subjects receiving standard care after 24 h; the secondary outcomes were pain scores at awakening and at 48 h together with distress (delirium) at awakening.
Two patients from the T group experienced a post-surgery bleeding, and one of them required revision of the hemostasis under general anesthesia. A preliminary analysis of pain sensation reported by the patients or caregivers did not show differences between treated and untreated subjects.
These data suggest that PBMT could increase post-surgical bleeding.
扁桃体切除术是儿童中最常见的外科手术之一,用于治疗因扁桃体肥大或高度复发性扁桃体炎引起的阻塞性睡眠呼吸暂停。吞咽痛在术后最初几天与拒食相关,是一种常见的术后主诉。现有的疼痛管理药物虽然有效,但存在一些缺点,因此需要一种新的策略。在这种情况下,光生物调节(PBMT)与药物治疗一起可能是一种选择。本研究的目的是评估PBMT与标准疼痛治疗相比,在不同时间点对伤害性感觉和止痛药给药的影响。
进行了一项注册、对照、随机、双盲临床试验。招募了22名患者,根据随机分配分为激光治疗组(T)或未治疗组(UT)。在T组中,采用冷剥离技术进行扁桃体切除术后,立即将激光照射到手术部位(使用意大利特雷维索的Eltech K-Laser s.r.l.公司生产的Cube 4),然后使用次没食子酸铋糊剂进行止血。在C组中,进行相同的操作,但关闭激光。主要结局是接受光生物调节(PBMT)的受试者与接受标准护理的受试者在24小时后的疼痛评分差异;次要结局是醒来时和48小时时的疼痛评分以及醒来时的痛苦(谵妄)。
T组有两名患者术后出血,其中一名需要在全身麻醉下进行止血修正。对患者或护理人员报告的疼痛感觉的初步分析显示,治疗组和未治疗组之间没有差异。
这些数据表明,PBMT可能会增加术后出血。